To help you understand what is going on in the healthcare industry and what we expect to happen in the future, our highly experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts (Get a free issue of The Kiplinger Letter or subscribe). You'll get all the latest news first by subscribing, but we will publish many (but not all) of the forecasts a few days afterward online. Here’s the latest...
If you’re worried about healthcare costs, for either your business or your personal situation, a raft of money-saving shifts are coming to the healthcare sector, promising to ease the strain on overburdened hospitals, while reducing expenses for patients and employers, who foot a lot of the bill.
One key to controlling future medical costs: moving more care to outpatient settings, meaning the patient goes home after a procedure instead of spending one or more nights recuperating in the hospital. It’s probably what most people want to begin with, and it can save a bundle vs a long stay in the hospital, especially with hospitals short-staffed.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Outpatient care will grow 18% by 2033, well ahead of the expected 2% rise in inpatient care. More surgeries will become outpatient as surgical techniques and post-surgery treatment are refined, reducing the need for hospitalization. More joint replacements, for instance, with patients going home to begin recovery and physical therapy.
Other conditions for which treatment will be offered much more often in outpatient settings are dementia, cancer, cardiovascular problems like chronic heart failure, diabetes and lung disease. Telemedicine is also poised to mushroom after catching on in the pandemic. A decade from now, remote visits will account for 26% of all appointments with doctors.
Advances in medical technology also promise to curb healthcare costs. Laparoscopic and other “keyhole” surgeries are being used more widely, enabling faster, less expensive recoveries. The growing use of surgical robots and improvements in robotics are expanding the array of minimally invasive surgeries.
Cheaper alternatives to blockbuster drugs should provide more cost relief. Biosimilars, which closely mimic original drugs, are proliferating. For example, a biosimilar version of AbbVie’s blockbuster arthritis treatment Humira hit the market earlier this year at a lower cost. Other biosimilars targeting popular drugs are coming. Eventually, they could lower prescription costs similarly to how generics have done.
The downside of better medical treatments: more people tend to use them, driving up overall health spending. The growing array of obesity drugs, for example, could improve the lives of millions and cut medical costs associated with obesity. But they figure to be very popular and will fuel a burst of additional drug spending.
There’s more competition coming to the healthcare market, too. Basic care is especially ripe for cost containment as new players offer inexpensive clinics to treat routine, nonemergency issues. Amazon Clinic, for instance, is now operating in all 50 states, offering low, fixed prices for 30 common conditions. Walmart Health operates in five states and treats a range of medical, behavioral and dental issues
This forecast first appeared in The Kiplinger Letter, which has been running since 1923 and is a collection of concise weekly forecasts on business and economic trends, as well as what to expect from Washington, to help you understand what’s coming up to make the most of your investments and your money. Subscribe to The Kiplinger Letter.
Related stories
-
Kiplinger Outlook: Telecom Companies Brace for Tough TimesThe Letter The telecom industry is entering a new era that threatens profitability. But the coming Trump administration will make it easier for the major players to adjust.
-
Start-ups Trying to (Profitably) Solve the World’s Hardest ProblemsThe Letter More investors are interested in companies working on breakthrough science to tackle huge societal challenges. The field of deep tech has major tailwinds, too.
-
Will lower mortgage rates bring relief to the housing market?The Kiplinger Letter As mortgage rates slowly come down here's what to expect in the housing market over the next year or so.
-
The Big Questions for AR’s FutureThe Letter As Meta shows off a flashy AR prototype, Microsoft quietly stops supporting its own AR headset. The two companies highlight the promise and peril of AR.
-
China's Economy Faces Darkening OutlookThe Letter What the slowdown in China means for U.S. businesses.
-
AI Start-ups Keep Scoring Huge SumsThe Kiplinger Letter Investors continue to make bigger bets on artificial intelligence start-ups, even for small teams with no revenue. Some backers think a startling tech breakthrough is near.
-
Should We Worry About the Slowing U.S. EconomyThe Letter With the labor market cooling off and financial markets turning jittery, just how healthy is the economy right now?
-
New Phones Get All the Hype, but Consumers Still Love Old Models
The Letter Even as flashy artificial intelligence features drive sales of new smartphones, used phones continue to fetch big bucks as demand outstrips supply.
